Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. Last February ...

Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...

Goldenberries (Physalis peruviana) are small, round fruits belonging to the nightshade family, which also includes tomatoes and eggplants. Each berry is enclosed in a papery husk and typically ...

CRISPR has incurred nearly $500 million in losses over the past four quarters. It's burning through cash as the result of its its gene-editing therapy's slow rollout. But its development partner, ...

CRISPR has incurred nearly $500 million in losses over the past four quarters. It's burning through cash as the result of its its gene-editing therapy's slow rollout. But its development partner, ...

A graphic representation of a round, lumpy, blue protein and a single, comblike, purple strand of RNA interacting with a twisted, double, blue strand of DNA that separates where it meets the RNA. A ...

Crops around the world are under pressure from high temperatures, unpredictable weather patterns and disease. Something must be done to protect them. Gene editing in agriculture can make crops more ...

CRISPR Therapeutics (CRSP) earns a Hold rating as pipeline breadth grows but CASGEVY's launch remains slow and economically unattractive. CRSP’s in vivo editing platform shows strong early validation, ...

The gene editor CRISPR is tackling fatty molecules in the body that contribute to one of the world’s top killers: cardiovascular disease. With a single injection, their flagship formulation lowered ...

Genome editing has been a long goal in molecular biology, medicine, and biotechnology, dating back to the discovery of restriction enzymes. However, the identification of zinc-finger nucleases (ZFN) ...

CRISPR has turned a simple fungus into a fast-growing, meat-like protein source with impressively low environmental impact. (A picture of Fusarium venenatum.) Credit: Xiao Liu Researchers used CRISPR ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...